ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
ANPto2Dollars
|
246 |
70K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
246
|
70K
|
4
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
ANPto2Dollars
|
246 |
70K |
9 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
246
|
70K
|
9
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
ANPto2Dollars
|
393 |
97K |
10 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
393
|
97K
|
10
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
ANPto2Dollars
|
393 |
97K |
5 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
393
|
97K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Inflammation a company maker
|
|
ANPto2Dollars
|
4 |
1.5K |
5 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
4
|
1.5K
|
5
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
ANPto2Dollars
|
1.0K |
297K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
1.0K
|
297K
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
ANPto2Dollars
|
1.0K |
297K |
2 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
1.0K
|
297K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Wilsons Report - 27c 12-month target
|
|
ANPto2Dollars
|
7 |
2.9K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
7
|
2.9K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
ANPto2Dollars
|
43 |
13K |
2 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
43
|
13K
|
2
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
ANPto2Dollars
|
161 |
38K |
4 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
161
|
38K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
ANPto2Dollars
|
92 |
34K |
1 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
92
|
34K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
4 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
3 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
1 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notification of cessation of securities - ANP
|
|
ANPto2Dollars
|
1 |
825 |
3 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
1
|
825
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
ANPto2Dollars
|
1.0K |
297K |
4 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
1.0K
|
297K
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
5 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
7 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
3 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
ANPto2Dollars
|
1.0K |
297K |
17 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
1.0K
|
297K
|
17
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
ANPto2Dollars
|
1.0K |
297K |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
1.0K
|
297K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces the Appointment of Non-Executive Chairman
|
|
ANPto2Dollars
|
76 |
16K |
12 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
76
|
16K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual General Meeting Presentation
|
|
ANPto2Dollars
|
81 |
20K |
3 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
81
|
20K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
ANPto2Dollars
|
45 |
11K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
45
|
11K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
ANPto2Dollars
|
413 |
164K |
5 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
413
|
164K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
ANPto2Dollars
|
413 |
164K |
4 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
413
|
164K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ANPto2Dollars
|
12 |
3.2K |
9 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
12
|
3.2K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ANPto2Dollars
|
12 |
3.2K |
7 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
12
|
3.2K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
ANPto2Dollars
|
413 |
164K |
10 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
413
|
164K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
ANPto2Dollars
|
413 |
164K |
9 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
413
|
164K
|
9
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
8 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
6 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
6
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
7 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
3 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
ANPto2Dollars
|
45 |
11K |
5 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
45
|
11K
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
4 |
14/10/23 |
14/10/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
0 |
14/10/23 |
14/10/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy
|
|
ANPto2Dollars
|
65 |
16K |
26 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
65
|
16K
|
26
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
5 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
4 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
12 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
12
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
11 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
11
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
9 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
9
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
ANPto2Dollars
|
1.0K |
297K |
1 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
1.0K
|
297K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
18 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
18
|
|
Charts
|
PER |
Re:
Chart
|
|
ANPto2Dollars
|
5.9K |
2.2M |
2 |
30/08/23 |
30/08/23 |
Charts
|
5.9K
|
2.2M
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
8 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
14 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
14
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
ANPto2Dollars
|
3.5K |
1.0M |
4 |
26/08/23 |
26/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Annual Report
|
|
ANPto2Dollars
|
8 |
3.4K |
17 |
26/08/23 |
26/08/23 |
ASX - By Stock
|
8
|
3.4K
|
17
|
|